Medication info
Lercanidipine Tablets (Lercanidipine Hydrochloride)

Lercanidipine Tablets (Lercanidipine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Lercanidipine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Korea Prime Pharma Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200503246 · Notified 2005.06.28 · Insurance code 663600340

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become clear. In patients whose blood pressure is not controlled with this medicine, combination treatment with a beta-blocker (e.g., atenolol), diuretic (e.g., hydrochlorothiazide), or ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; higher doses do not further increase efficacy and instead increase adverse reactions. ○ Older adults : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in older adults. ○ Patients with hepatic or renal impairment : Special caution is required when initiating treatment in patients with mild to moderate hepatic or renal impairment. Although the usual dose regimen is consistent in these patients, caution is required when increasing the dose to 20 mg per day. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, and dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
Korea Prime Pharma Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension that falls within the mild to moderate range.

How to take

Adult dose

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become clear. In patients whose blood pressure is not controlled with this medicine, combination treatment with a beta-blocker (e.g., atenolol), diuretic (e.g., hydrochlorothiazide), or ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; higher doses do not further increase efficacy and instead increase adverse reactions. ○ Older adults : Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in older adults. ○ Patients with hepatic or renal impairment : Special caution is required when initiating treatment in patients with mild to moderate hepatic or renal impairment. Although the usual dose regimen is consistent in these patients, caution is required when increasing the dose to 20 mg per day. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, and dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Precautions

This drug should not be administered to certain patients. For example, those who are allergic to this drug or similar drugs, women who are pregnant or may become pregnant, and individuals who are breastfeeding should not take this drug. Additionally, patients with heart problems, very poor liver or kidney function, those who have recently suffered a myocardial infarction, patients undergoing dialysis, and children or adolescents under 18 years of age are also not recommended to use this drug. This drug contains lactose, so those with lactose intolerance or related genetic disorders should not take it. Caution is required for specific patient groups when using this drug. For example, individuals with problems with cardiac pacemakers or weak heart function, those with mild to moderate liver or kidney disorders, or those with a history of angina should use this drug cautiously. Also, alcohol consumption may enhance the blood pressure-lowering effect of this drug, so care is needed, and special caution is required for the elderly. While taking this drug, symptoms may occur such as flushing, swelling of hands and feet, and rapid heart rate, and rarely, low blood pressure or chest pain may occur. Symptoms such as headache, dizziness, fatigue, indigestion, nausea, abdominal pain, and diarrhea may also be experienced. It is important to have regular liver function tests as liver function abnormalities may occur, and if abnormalities are found, the medication should be stopped immediately. This drug may cause drowsiness or lethargy, so caution is required when driving or operating machinery. This drug is metabolized in the liver, and interactions may occur when taken with specific drugs. Particularly, medicines that inhibit or activate enzymes involved in liver metabolism should be discussed with a doctor or pharmacist before concurrent use. It is advisable to avoid taking this drug with grapefruit juice as it may increase drug concentrations. Women who are pregnant or breastfeeding should not take this drug, and those planning for pregnancy should consult with healthcare professionals. The safety and efficacy of this drug have not been established in children or adolescents, therefore, it should not be used in these populations. In case of overdose, severe hypotension or heart problems may occur, so if any abnormal symptoms arise, medical attention should be sought immediately. Finally, this drug should be kept out of reach of children, and it is safe not to transfer it to other containers.

Side effects

Flushing, peripheral edema, palpitations, tachycardia, hypotension, chest pain, angina, headache, dizziness, weakness, fatigue, drowsiness, neurosis, dyspepsia, nausea, vomiting, abdominal pain, diarrhea, increased serum levels of liver aminotransferases, polyuria, urinary frequency, gingival hyperplasia, rash, myalgia, tremors, insomnia, dry mouth, hand numbness, cough, abdominal bloating, erectile dysfunction, arrhythmia, cold sweat, skin tingling, premature contractions, tongue stiffness, increased ventricular premature beats, shortness of breath, gastrointestinal disturbances

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to avoid exposure to air or moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps to maintain the effectiveness and safety of the medication over a long period.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.